Key facts
- A director of Ionis Pharmaceuticals sold company stock.
- The value of the shares sold was $605,360.
- The transaction was disclosed in a recent SEC filing.
A director of Ionis Pharmaceuticals has sold company stock valued at $605,360. The transaction, which involved the sale of company shares, was disclosed in a recent filing with the U.S. Securities and Exchange Commission (SEC). Such filings are typically made under Form 4, which reports changes in beneficial ownership of securities by a company's insiders.
